Wells Fargo & Company Vericel Corp Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Vericel Corp stock. As of the latest transaction made, Wells Fargo & Company holds 69,975 shares of VCEL stock, worth $3.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,975

Previous 62,612 11.76%

Holding current value

$3.99 Million

Previous $2.65 Million 45.26%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$40.05 - $59.11 $294,888 - $435,226	7,363 Added 11.76%	69,975 $3.84 Million
Q3 2024 Nov 13, 2024	SELL	$42.25 - $53.56 $138,199 - $175,194	-3,271 Reduced 4.96%	62,612 $2.65 Million
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $55,390 - $70,251	1,328 Added 2.06%	65,883 $3.02 Million
Q1 2024 May 10, 2024	SELL	$32.52 - $52.33 $24,780 - $39,875	-762 Reduced 1.17%	64,555 $3.36 Million
Q4 2023 Feb 09, 2024	SELL	$30.85 - $37.09 $703,164 - $845,392	-22,793 Reduced 25.87%	65,317 $2.33 Million
Q3 2023 Nov 13, 2023	SELL	$31.69 - $39.25 $206,935 - $256,302	-6,530 Reduced 6.9%	88,110 $2.95 Million
Q2 2023 Aug 15, 2023	BUY	$29.0 - $38.37 $191,255 - $253,050	6,595 Added 7.49%	94,640 $3.56 Million
Q1 2023 May 12, 2023	BUY	$23.85 - $31.34 $834,273 - $1.1 Million	34,980 Added 65.92%	88,045 $2.58 Million
Q4 2022 Feb 13, 2023	SELL	$17.65 - $27.37 $194,591 - $301,754	-11,025 Reduced 17.2%	53,065 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $43,724 - $62,899	-1,933 Reduced 2.93%	64,090 $1.49 Million
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $5.87 Million - $10.1 Million	-256,593 Reduced 79.54%	66,023 $1.66 Million
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $103,024 - $140,735	3,251 Added 1.02%	322,616 $12.3 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $30.3 Million - $45.3 Million	-860,338 Reduced 72.93%	319,365 $12.6 Million
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $7.66 Million - $9.88 Million	165,355 Added 16.3%	1,179,703 $57.6 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $993,418 - $1.43 Million	-21,047 Reduced 2.03%	1,014,348 $53.3 Million
Q1 2021 May 13, 2021	SELL	$30.93 - $59.48 $5.43 Million - $10.4 Million	-175,536 Reduced 14.5%	1,035,395 $57.5 Million
Q4 2020 Feb 09, 2021	SELL	$18.53 - $31.5 $336,338 - $571,756	-18,151 Reduced 1.48%	1,210,931 $37.4 Million
Q3 2020 Nov 05, 2020	BUY	$14.68 - $19.12 $288,359 - $375,574	19,643 Added 1.62%	1,229,082 $22.8 Million
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $2.02 Million - $3.77 Million	238,036 Added 24.5%	1,209,439 $16.7 Million
Q1 2020 May 14, 2020	BUY	$7.25 - $19.22 $7.04 Million - $18.7 Million	971,403 New	971,403 $8.91 Million

Others Institutions Holding VCEL

# of Institutions

291

Shares Held

50.8M

Call Options Held

139K

Put Options Held

68.5K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.69B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Vericel Corp Transaction History